Russell Investments Group’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
CIAM
QC
DJYG
SOW
FCG
MMA
Russell Investments Group's STIM Position: Q2 2026 in Review
Russell Investments Group increased its Neuronetics (STIM) stake by 171% in Q2 2026, buying an estimated $8.12K and bringing the position to 8,839 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3910.
Russell Investments Group first reported a position in STIM in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.85M in Q1 2021. 23 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- Russell Investments Group held 8,839 shares of Neuronetics worth $11.5K as of Q2 2026.
- Russell Investments Group bought 5,582 Neuronetics shares in Q2 2026, an estimated $8.12K.
- Neuronetics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3910 holding.
- Russell Investments Group first reported a position in Neuronetics in Q2 2018 and has held it in 11 quarters since.
- Russell Investments Group's Neuronetics position peaked at $3.85M in Q1 2021.
- 23 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.